The identification of FGF receptors and β-Klotho co-receptors within intestinal tissues supports the hypothesis that FGF21 plays a role in intestinal pathophysiology of IBD (Danopoulos et al., 2017; Aaldijk et al., 2023). This evidence concerns the gene FGF21 and inflammatory bowel disease.